Rigel Pharmaceuticals (RI2.F) Q1 2026 Earnings

3MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
0.08
3.94
7.8
11.66

Details

Expected EPS
1.03432231673
Actual EPS
11.6564506
Surprise EPS
10.62
Surprise Percent
+1,026.97%

Description

Rigel Pharmaceuticals (RI2.F) has reported earnings of 11.6564506 per share for Q1 2026.

0 Comments

Share your thoughts